A technology has been developed that can screen for lung cancer at an early stage using exhaled breath. This technology demonstrated 95% accuracy in clinical settings. It is expected to contribute to ...
In a recent opinion piece published in the journal Trends in Cancer, researchers examined the rising global burden of lung cancer in people with no history of smoking. This phenomenon requires its own ...
For most of the last century, a diagnosis of lung cancer was often regarded as a death sentence. As an oncologist, I have witnessed dramatic changes over the past two decades, particularly in the last ...
bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...
Make this your preferred source to get more updates from this publisher on Google. Higher mortality rates due to lung cancer may be avoided if there is increased early detection of the disease, ...
PARIS--(BUSINESS WIRE)--Sensome, the pioneer of microsensing technology for real-time, intra-operative tissue analysis, today announced positive results from its first-in-human INSPECT study ...
A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する